Form D · Pharmaceuticals
Lipocine Inc.
Salt Lake City, X1 · CIK 0001535955
Offering snapshot reported Aug 5, 2013 · SEC filing
- Reported sold
- $38M Offering amount: $38M
- Investors reported
- 27 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 30, 2013 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 5, 2013 | Initial | $38,019,984 | No comparison | 27 | SEC filing |
| Aug 5, 2013 | Initial | $0 | No comparison | 100 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $1.9M
- Finders' fees
- $0
- Form D file number
- 021-200776
5% of gross proceeds.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Ladenburg Thalmann & Co., Inc. | 505 | Ladenburg Thalmann & Co., Inc. · CRD 505 |
Source: Form D, filed Aug 5, 2013. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| William I. Higuchi | Director |
| John W. Higuchi | Director |
| Robert K. Merrell | Executive |
| Mahesh V. Patel | Director, Executive |
| Gordhan Patel | Director |
| Gerald Simmons | Executive |
| Srinivasan Venkateshwaran | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
675 Arapeen Drive, Suite 202
Salt Lake City, X1, 84108
Salt Lake City, X1, 84108